Industry: Life Sciences Region: Sweden Transaction Price: US $1million Transaction Method: Equity investment
Project Introduction:
With multiple intellectual property rights and extensive experience in developing small wireless sensor systems for medical or industrial use, the company has developed applications capable of meeting the industry's requirements for low power consumption, long run time, high reliability, miniaturization and harsh environmental conditions.
The company's breakthrough ECG technology replaces stationary ECG devices and portable ECG systems used in hospital intensive care units with low-cost, high-quality ECG monitoring.
The system includes a one-time ECG registration and transmission unit, a receiving unit called Cardiobase ®, and a back-end system for displaying, storing, and processing ECG information.
The basic idea is to use a low-cost disposable device to measure ECG in a completely wireless manner, enabling a common wired disposable electrode method without having to connect any wires, and eliminating the problem of electrode or wire loss.
The company's patented ECG measurement technology makes it possible to measure all forms of ECG using a single-use stand-alone device (up to 12mm). The CardioPatch® sensor is attached to the body through an adhesive in the same way as a conventional ECG electrode, but the CardioPatch® is a fully integrated unit that contains an electrode, an ECG amplifier, a radio transmitter and an identification device.
The electrodes on the patch are standard types of hydrogels used for ECG measurements, and the electrodes are connected to unique and patented measurement electronics.
The equipment will be manufactured using process technology so that it can be mass-produced at low cost.
Cooperation Intention:
The company hopes to seek strategic partners in the Chinese market to jointly develop the Chinese market.